| Clinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial Y Ray, SR Paul, P Bandopadhyay, R D’Rozario, J Sarif, A Lahiri, ... MedRxiv, 2020.11. 25.20237883, 2020 | 74 | 2020 |
| FnCas9-based CRISPR diagnostic for rapid and accurate detection of major SARS-CoV-2 variants on a paper strip M Kumar, S Gulati, AH Ansari, R Phutela, S Acharya, M Azhar, J Murthy, ... Elife 10, e67130, 2021 | 65 | 2021 |
| A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19 Y Ray, SR Paul, P Bandopadhyay, R D’Rozario, J Sarif, D Raychaudhuri, ... Nature Communications 13 (1), 383, 2022 | 35 | 2022 |
| COVID-19 Risk Stratification and Mortality Prediction in Hospitalized Indian Patients: Harnessing clinical data for public health benefits S Alle, A Kanakan, S Siddiqui, A Garg, A Karthikeyan, P Mehta, N Mishra, ... PLoS One 17 (3), e0264785, 2022 | 32 | 2022 |
| Increased abundance of Achromobacter xylosoxidans and Bacillus cereus in upper airway transcriptionally active microbiome of COVID-19 mortality patients indicates role of co … P Devi, R Maurya, P Mehta, U Shamim, A Yadav, P Chattopadhyay, ... Microbiology Spectrum 10 (3), e02311-21, 2022 | 27 | 2022 |
| Clinical, serological, whole genome sequence analyses to confirm SARS-CoV-2 reinfection in patients from Mumbai, India J Shastri, S Parikh, S Agrawal, N Chatterjee, M Pathak, S Chaudhary, ... Frontiers in medicine 8, 631769, 2021 | 25 | 2021 |
| SARS-CoV-2 mutations and COVID-19 clinical outcome: mutation global frequency dynamics and structural modulation hold the key R Maurya, P Mishra, A Swaminathan, V Ravi, S Saifi, A Kanakan, P Mehta, ... Frontiers in cellular and infection microbiology 12, 868414, 2022 | 22 | 2022 |
| Whole genome sequencing confirmed SARS-CoV-2 reinfections among healthcare workers in India with increased severity in the second episode J Shastri, S Parikh, S Agarwal, N Chatterjee, M Pathak, C Sharma, ... | 22 | 2020 |
| Kinetics of viral load, immunological mediators and characterization of a SARS-CoV-2 isolate in mild COVID-19 patients during acute phase of infection A Anantharaj, S Gujjar, S Kumar, N Jain, J Wangchuk, NA Khan, ... MedRxiv, 2020.11. 05.20226621, 2020 | 11 | 2020 |
| Clinico-genomic analysis reveals mutations associated with COVID-19 disease severity: possible modulation by RNA structure P Mehta, S Alle, A Chaturvedi, A Swaminathan, S Saifi, R Maurya, ... Pathogens 10 (9), 1109, 2021 | 10 | 2021 |
| Isolation and Characterization of Human Intestinal Bacteria Cytobacillus oceanisediminis NB2 for Probiotic Potential M Yadav, T Kumar, A Kanakan, R Maurya, R Pandey, NS Chauhan Frontiers in Microbiology 13, 932795, 2022 | 9 | 2022 |
| Geographical landscape and transmission dynamics of SARS-CoV-2 variants across India: a longitudinal perspective N Jha, D Hall, A Kanakan, P Mehta, R Maurya, Q Mir, HM Gill, SC Janga, ... Frontiers in Genetics 12, 753648, 2021 | 9 | 2021 |
| Threading the pieces together: integrative perspective on SARS-CoV-2 A Kanakan, N Mishra, J Srinivasa Vasudevan, S Sahni, A Khan, ... Pathogens 9 (11), 912, 2020 | 9 | 2020 |
| Clinico-Genomic Analysis Reiterates Mild Symptoms Post-vaccination Breakthrough: Should We Focus on Low-Frequency Mutations? A Kanakan, P Mehta, P Devi, S Saifi, A Swaminathan, R Maurya, ... Frontiers in Microbiology 13, 763169, 2022 | 6 | 2022 |
| Learning from biological and computational machines: importance of SARS-CoV-2 genomic surveillance, mutations and risk stratification S Bhat, A Pandey, A Kanakan, R Maurya, JS Vasudevan, P Devi, ... Frontiers in Cellular and Infection Microbiology 11, 783961, 2021 | 6 | 2021 |
| A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19. Nat Commun. 2022; 13: 383 Y Ray, SR Paul, P Bandopadhyay, R D’Rozario, J Sarif, D Raychaudhuri, ... | 5 | |
| Reinfection or reactivation: Genome‐based two distinct SNP profile of SARS‐CoV2 repositivity in an Indian case MS Dhar, V Asokachandran, B Uppili, N Tyagi, P Sharma, S Tiwari, ... Journal of Medical Virology 93 (7), 4152, 2021 | 4 | 2021 |
| Infection outcome needs two to tango: human host and the pathogen R Maurya, A Kanakan, JS Vasudevan, P Chattopadhyay, R Pandey Briefings in Functional Genomics 21 (2), 90-102, 2022 | 3 | 2022 |
| RAY: CRISPR diagnostic for rapid and accurate detection of SARS-CoV2 variants on a paper strip M Kumar, S Gulati, AH Ansari, R Phutela, S Acharya, P Kathpalia, ... MedRxiv, 2021.02. 01.21250900, 2021 | 3 | 2021 |
| COVID-19 risk stratification and mortality prediction in hospitalized Indian patients S Alle, S Siddiqui, A Kanakan, A Garg, A Karthikeyan, N Mishra, ... medRxiv, 2020.12. 19.20248524, 2020 | 3 | 2020 |
